BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2459894)

  • 1. Hemiballismus: changes in cerebrospinal fluid.
    Kostic V; Djuricic B; Paschen W
    Acta Neurol Scand; 1988 Aug; 78(2):115-7. PubMed ID: 2459894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
    Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
    Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of drug-induced changes in dopamine and serotonin metabolite concentrations in the CSF of the rat.
    Mignot E; Laude D; Elghozi JL
    J Neurochem; 1984 Mar; 42(3):819-25. PubMed ID: 6198472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine metabolites in the CSF of conscious unrestrained cats.
    Degrell I; Zenner K; Kummer P; Stock G
    Brain Res; 1983 Oct; 277(2):283-7. PubMed ID: 6196083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraventricular microdialysis: a new method for determining monoamine metabolite concentrations in the cerebrospinal fluid of freely moving rats.
    Becker JB; Adams F; Robinson TE
    J Neurosci Methods; 1988 Jul; 24(3):259-69. PubMed ID: 2458511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmortem changes in the levels of monoamine metabolites in human cerebrospinal fluid.
    Endo T; Hara S; Kuriiwa F; Kano S
    Forensic Sci Int; 1990 Jan; 44(1):61-8. PubMed ID: 1689267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF HVA and 5-HIAA.
    Wood JH
    Neurology; 1979 Jun; 29(6):910-12. PubMed ID: 572023
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of rat ovariectomy on CSF monoamine metabolite levels and elimination.
    Duval C; Mignot E
    J Neurochem; 1985 Apr; 44(4):1312-4. PubMed ID: 2579209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders.
    Tabaddor K; Wolfson LI; Sharpless NS
    Neurology; 1978 Dec; 28(12):1249-53. PubMed ID: 569783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Homovanillic (HVA) and 5-hydroxyindoleacetic (5-HIAA) acid concentration in the cerebrospinal fluid of patients with supratentorial tumors and symptoms of intracranial hypertension (preliminary report)].
    Majchrzak H; Kmieciak-KoĊ‚ada K; Herman Z; Wencel T
    Neurol Neurochir Pol; 1980; 14(1):87-90. PubMed ID: 6154903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF monamine metabolites in movement disorders and normal aging.
    Stahl SM; Faull KF; Barchas JD; Berger PA
    Arch Neurol; 1985 Feb; 42(2):166-9. PubMed ID: 2579626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid.
    Cohen DJ; Shaywitz BA; Johnson WT; Bowers M
    Arch Gen Psychiatry; 1974 Dec; 31(6):845-53. PubMed ID: 4441252
    [No Abstract]   [Full Text] [Related]  

  • 13. Concentrations of homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid from human infants in the perinatal period.
    Silverstein FS; Donn S; Buchanan K; Johnston MV
    J Neurochem; 1984 Dec; 43(6):1769-72. PubMed ID: 6208340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
    Soininen H; MacDonald E; Rekonen M; Riekkinen PJ
    Acta Neurol Scand; 1981 Aug; 64(2):101-7. PubMed ID: 6172950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cerebrospinal fluid levels of dopamine metabolites by gas chromatography.
    Watson E; Wilk S
    Psychopharmacologia; 1975 Apr; 42(1):57-6. PubMed ID: 1153623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Central metabolism of dopamine and serotonin. IV. Preliminary determinations of cerebrospinal fluid HVA and 5-HIAA in epileptic syndromes].
    Mandarini A; Buscaino GA; Rossi V; Orefice G; Carrieri P; Campanella G
    Acta Neurol (Napoli); 1976; 31(5):628-31. PubMed ID: 1015386
    [No Abstract]   [Full Text] [Related]  

  • 17. Reye syndrome: monoamine metabolites in ventricular fluid.
    Shaywitz BA; Venes J; Cohen DJ; Bowers MB
    Neurology; 1979 Apr; 29(4):467-72. PubMed ID: 571546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)].
    Carrieri P; Campanella G; Mandarini A; Orefice G; Buscaino GA
    Acta Neurol (Napoli); 1976; 31(5):558-64. PubMed ID: 1015382
    [No Abstract]   [Full Text] [Related]  

  • 19. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method.
    Mena MA; Aguado EG; de Yebenes JG
    Acta Neurol Scand; 1984 Apr; 69(4):218-25. PubMed ID: 6204498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.